The association between the presence of self-splicing intron Ca.LSU and proteolytic activity of Candida albicans isolates was tested. Study included 95 C. albicans strains isolated from gastrointestinal tract of diabetes children. The strains with the intron (genotype B) displayed a significantly higher proteolytic activity (385.2 ± 192U/L) than did strains without intron (genotype A) (119 ± 115U/L) (p = 0.0000048).
Blignaut E., C. Pujol, S. Lockhart, S. Joly and D.R. Soll. 2002. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa. J. Clin. Microbiol. 40: 826-36.
Hube B. 2000. Extracellular proteinases of human pathogenic fungi, p. 126-137. In: J.E. Ernst and A. Schmidt (eds), Dimorphism in Human Pathogenic and Apathogenic Yeasts. Contrib. Microbiol. Basel. Karger.
Lott T.J. and M.M. Effat. 2001. Evidence for a more recently evolved clade within a Candida albicans North American population. Microbiology 147: 1687-92.
Lott T.J., B.P. Holloway, D.A. Logan, R. Fundyga and J. Arnold. 1999. Towards understanding the evolution of the human commensal yeast Candida albicans. Microbiology 145: 1137-43.
McCullough M.J., K.V. Clemons and D.A. Stevens. 1999. Molecular and phenotypic characterisation of genotypie Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J. Clin. Microbiol. 37: 417-421.
Mercury S., S. Montplaisir and G. Lemay. 1993. Correlation between the presence of a self-splicing intron in the 25S rDNA of C. albicans and strains susceptibility to 5-fluorocytosine. Nucleid Acids Res. 21: 6020-6027.
Millar B.C., J.E. Moore, J. Xu, M.J. Walker, S. Hedderwick and R. McMullan. 2002. Genotypie subgrouping of clinical isolates of Candida albicans and Candida dubliniensis by 25S intron analysis. Lett. Appl. Microbiol. 35: 102-6.
Monod M., S. Capoccia, B. Lechenne, C. Zaugg, M. Holdom and O. Jousson. 2002. Secreted proteases from pathogenic fungi. Int. J. Med. Microbiol. 292: 405-19.
Remold H., H. Fasold and F. Staib. 1968. Purification and characterisation of proteolytic enzyme from Candida albicans. Biochim. Biophys. Acta. 167: 399-406.
Rose M.D., F. Winston and P. Hietr. 1990. Methods in yeast genetics. A laboratory course manual. Cold Spring Harbor Laboratory Press, Cold Sprin Harbor, NY.
Sugita T., S. Kurosaka, M. Yajitate, H. Sato and A. Nishikawa. 2002. Extracellular proteinase and phospholipase activity of three genotypie strains of a human pathogenic yeast, Candida albicans. Microbiol. Immunol. 46: 881-3.
Tamura M., K. Watanabe, Y. Mikami, K. Yazawa and K. Nishimura. 2001. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J. Clin. Microbiol. 39: 4309-15.
Zhang Y, Z. L i, D.S. Pilch and M.J. Leibowitz. 2002. Pentamidine inhibits catalytic activity of group I intron Ca.LSU by altering RNA folding. Nucleic Acids Res. 30: 2961-71.